Concepedia

Paul Vink

PV

15

Publications

1.4K

Citations

14

H-Index

2008

Active since

Affiliations

Radboud University Nijmegen(Current)

Radboud University Medical Center

Merck (Netherlands)

Merck & Co., Inc., Rahway, NJ, USA (United States)

University Medical Center Groningen

Paul Vink is an author at Radboud University Nijmegen specializing in medicine, immunology, and cell biology.

Top concepts

Publications per year

2008–2023

15

Publications

15

Human CD25highFoxp3pos regulatory T cells differentiate into IL-17–producing cells

Hans J. P. M. Koenen, Ruben L. Smeets, Paul Vink et al. · Blood · 2008 · 721 citations · Full text

Molecular mechanism of respiratory syncytial virus fusion inhibitors

Michael B. Battles, Johannes P. M. Langedijk, Polina Furmanova-Hollenstein et al. · Nature Chemical Biology · 2015 · 160 citations · Full text

, , +3

Mycophenolic Acid-Mediated Suppression of Human CD4+ T Cells: More Than Mere Guanine Nucleotide Deprivation

Xuehui He, Ruben L. Smeets, Hans J. P. M. Koenen et al. · American Journal of Transplantation · 2011 · 89 citations · Full text

, , +22

Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity

Mark Baugh, Darcey Black, Paul Westwood et al. · Journal of Autoimmunity · 2011 · 72 citations

, , +9

Functional characterization of the selective pan-allele anti-SIRPα antibody ADU-1805 that blocks the SIRPα–CD47 innate immune checkpoint

Erik Voets, Marc Paradé, D. Lutje Hulsik et al. · Journal for ImmunoTherapy of Cancer · 2019 · 65 citations · Full text

Rows per page

1–5 of 15